ProShare Advisors LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$30,079
-10.2%
17,488
+1.9%
0.00%
Q2 2023$33,477
-46.0%
17,168
+14.1%
0.00%
Q1 2022$62,000
-74.5%
15,041
-20.5%
0.00%
Q4 2021$243,000
+153.1%
18,912
+80.5%
0.00%
Q2 2021$96,000
-4.0%
10,476
-5.8%
0.00%
Q4 2019$100,00011,1210.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders